Skip to content

SANARA MEDTECH INC.: 10-Q filed 2021-11-12

What SANARA MEDTECH INC. reported in its quarterly report filed 2021-11-12 (fiscal Q3 2021): 42 published measures, 115 facts as tagged in accession 0001654954-21-012077.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-12
Fiscal period
fiscal Q3 2021
Accession
0001654954-21-012077 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANARA MEDTECH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3037,927,934USD
At 2020-12-319,826,221USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-304,505,302USD
At 2020-12-313,985,985USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3033,422,632USD
At 2021-06-3034,657,463USD
At 2021-03-3135,471,635USD
At 2020-12-315,840,236USD
At 2020-09-305,563,344USD
At 2020-06-305,613,653USD
At 2020-03-316,557,039USD
At 2019-12-316,392,400USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3022,371,434USD
At 2020-12-31455,366USD
At 2019-12-316,611,928USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-2,047,861USD92
2021-01-01 to 2021-09-30-4,437,210USD273
2021-04-01 to 2021-06-30-1,205,973USD91
2021-01-01 to 2021-03-31-1,183,376USD90
2020-07-01 to 2020-09-30-1,208,123USD92
2020-01-01 to 2020-09-30-4,178,692USD274
2020-04-01 to 2020-06-30-1,129,557USD91
2020-01-01 to 2020-03-31-1,841,012USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-3,030,168USD273
2020-01-01 to 2020-09-30-3,443,449USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-3030,157USD273
2020-01-01 to 2020-09-3057,456USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,823,942USD92
2021-01-01 to 2021-09-3017,110,511USD273
2020-07-01 to 2020-09-304,306,324USD92
2020-01-01 to 2020-09-3010,797,838USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-3028,739,257USD273
2020-01-01 to 2020-09-30609,220USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-3,793,021USD273
2020-01-01 to 2020-09-30-1,657,456USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-11,405,848USD
At 2020-12-31-7,032,242USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-301,581,298USD
At 2020-12-31678,589USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-30852,226USD273
2020-01-01 to 2020-09-30872,662USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,854,018USD92
2021-01-01 to 2021-09-30-3,963,752USD273
2020-07-01 to 2020-09-30-1,306,915USD92
2020-01-01 to 2020-09-30-4,182,555USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3027,229,549USD
At 2020-12-314,482,313USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-30711USD273
2020-07-01 to 2020-09-301,458USD92
2020-01-01 to 2020-09-3010,913USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-304,158,291USD
At 2020-12-313,539,895USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30321,391USD
At 2020-12-31271,251USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-09-304,835,854USD
At 2020-12-313,097,666USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-30171,440USD
At 2020-12-310USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-307,160,349USD92
2021-01-01 to 2021-09-3019,545,814USD273
2020-07-01 to 2020-09-305,165,304USD92
2020-01-01 to 2020-09-3013,853,595USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-301,552,350USD
At 2020-12-311,148,253USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,306,331USD92
2021-01-01 to 2021-09-3015,582,062USD273
2020-07-01 to 2020-09-303,858,389USD92
2020-01-01 to 2020-09-309,671,040USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-07-01 to 2021-09-30517,611USD92
2021-01-01 to 2021-09-301,528,449USD273
2020-07-01 to 2020-09-30447,935USD92
2020-01-01 to 2020-09-301,126,798USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-3035,674USD92
2021-01-01 to 2021-09-30257,867USD273
2020-07-01 to 2020-09-3011,022USD92
2020-01-01 to 2020-09-3011,022USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-307,632,044shares
At 2021-07-147,632,044shares
At 2020-12-316,297,008shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3045,300,968USD
At 2020-12-3113,176,576USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2021-09-3033,902,752USD
At 2020-12-316,150,631USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30469,702USD
At 2020-12-31467,653USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30482,856USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-09-301,833,436USD
At 2020-12-31803,280USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-09-30252,138USD
At 2020-12-31124,691USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-09-304,835,854USD
At 2020-12-313,097,666USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-3090,293USD
At 2020-12-3190,293USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-301,020,901USD
At 2020-12-31611,817USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-306,920,105USD92
2021-01-01 to 2021-09-3018,891,979USD273
2020-07-01 to 2020-09-305,072,402USD92
2020-01-01 to 2020-09-3013,632,967USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-01-01 to 2021-09-30127,448USD273
2020-01-01 to 2020-09-3050,593USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-01-01 to 2021-09-30268,520USD273
2020-01-01 to 2020-09-30159,013USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-193,843USD92
2021-01-01 to 2021-09-30-473,458USD273
2020-07-01 to 2020-09-3098,792USD92
2020-01-01 to 2020-09-303,863USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30101,916USD273
2020-01-01 to 2020-09-30-536,263USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-510,920USD273
2020-01-01 to 2020-09-30-299,888USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-3050,140USD273
2020-01-01 to 2020-09-30-62,934USD274

Inspect the source

Entity
SANARA MEDTECH INC. / CIK 0000714256
Captured
2026-09-19T14:58:44.284Z
SEC response SHA-256
f92965785fd765218c7d077735cf7f10feb84c027a40423c2ef31995cf28b81f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000714256.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))